The risk of cancer in users of statins.

  title={The risk of cancer in users of statins.},
  author={Matthijs R Graaf and Annette B. Beiderbeck and Antoine C. G. Egberts and Dick J. Richel and Henk-Jan Guchelaar},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  volume={22 12},
PURPOSE Several preclinical studies suggested a role for 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) in the treatment of cancer. The objective of this study was to compare the risk of incident cancer between users of statins and users of other cardiovascular medication. METHODS Data were used from the PHARMO database, containing drug dispensing records from community pharmacies and linked hospital discharge records for residents of eight Dutch cities. The study base… CONTINUE READING
Highly Influential
This paper has highly influenced 11 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS


Publications citing this paper.
Showing 1-10 of 174 extracted citations

Can statins reduce risk of lung cancer, especially among elderly people? A meta-analysis.

Chinese journal of cancer research = Chung-kuo yen cheng yen chiu • 2013
View 5 Excerpts
Highly Influenced

Statin use and risk of prostate cancer in the California Men's Health Study cohort.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology • 2007
View 4 Excerpts
Highly Influenced

ould drugs inhibiting the mevalonate pathway also target cancer tem cells ?

irginia Likusa, Krzysztof Siemianowiczb, +9 authors Marek J. Łosm
View 4 Excerpts
Highly Influenced

Cholesterol-lowering drugs and colorectal cancer incidence in a large United States cohort.

Journal of the National Cancer Institute • 2006
View 1 Excerpt
Highly Influenced

Statins and prostate cancer risk: a case-control study.

American journal of epidemiology • 2005
View 6 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…